Lincoln Pharmaceuticals Ltd.
| BSE: 531633 | Sector: Health care |
| NSE: LINCOLN | ISIN Code: INE405C01035 |
| BSE 00:00 | 15 Jun | 311.45 |
15.90 (5.38%) |
OPEN
295.30 |
HIGH
315.00 |
LOW
295.25 |
| NSE 00:00 | 15 Jun | 310.80 |
15.15 (5.12%) |
OPEN
292.70 |
HIGH
313.00 |
LOW
292.70 |
| OPEN | 295.30 |
| PREVIOUS CLOSE | 295.55 |
| VOLUME | 29679 |
| 52-Week high | 338.85 |
| 52-Week low | 154.20 |
| P/E | 10.31 |
| Mkt Cap.(Rs cr) | 623 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Lincoln Pharmaceuticals Ltd. (LINCOLN) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 993.30 | -1.05 | -0.11 | 13266.48 |
| Cipla | 969.60 | -6.60 | -0.68 | 12659.15 |
| Sun Pharma.Inds. | 673.20 | -4.05 | -0.60 | 12531.93 |
| Dr Reddy's Labs | 5414.90 | -44.65 | -0.82 | 11850.40 |
| Lupin | 1186.65 | -5.95 | -0.50 | 11025.66 |
| Apollo Hospitals | 3298.90 | -52.55 | -1.57 | 9794.50 |
| Glenmark Pharma. | 640.85 | -2.80 | -0.44 | 6712.63 |
| Alkem Lab | 3185.55 | -47.50 | -1.47 | 6677.08 |
| Cadila Health. | 646.30 | -8.90 | -1.36 | 6347.40 |
| Torrent Pharma. | 2925.00 | -54.65 | -1.83 | 6168.44 |
| Divi's Lab. | 4312.90 | -74.15 | -1.69 | 5310.57 |
| Ipca Labs. | 2066.20 | -28.30 | -1.35 | 4337.82 |
| Piramal Enterp. | 2218.10 | -2.60 | -0.12 | 4219.19 |
| Alembic Pharma | 997.60 | 3.05 | 0.31 | 4132.55 |
| Abbott India | 16452.15 | 170.65 | 1.05 | 4093.14 |
| Glaxosmi. Pharma | 1580.25 | -3.80 | -0.24 | 3224.68 |
| Jubilant Pharmo | 754.80 | -8.40 | -1.10 | 3139.90 |
| Sanofi India | 7749.65 | -64.70 | -0.83 | 2901.90 |
| Laurus Labs | 623.25 | 1.65 | 0.27 | 2797.34 |
| Gland Pharma | 3146.80 | -10.75 | -0.34 | 2633.24 |
Quick Links for Lincoln Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
